BMY logo

Bristol-Myers Squibb (BMY)

Profile

Full Name

Bristol-Myers Squibb Company

Ticker Symbol

BMY

Exchange

NYSE

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

United States

IPO

June 1, 1972

Indexes

S&P 500

Website

http://www.bms.com

Employees

34100

Key Details

Price

$49.52(-7.85%)

Market cap

$100.49B(Mega cap)

Last Dividend

$0.62

TTM Dividend yield

4.93%

Annual revenue

$48.30B(+7.32% YoY)

Annual EPS

-$4.41(-214.25% YoY)

PE ratio

-

Next earnings date

Apr 24, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$49.52
BMY price is $49.52

30-Day Relative Volume

1.41
BMY 30-day relative volume is 1.41

Price Performance

Price Today change

-7.85%
BMY price is down -7.85% today

Price YTD change

-12.45%
BMY price is down -12.45% since January 1st

Price 1-year change

-1.53%
BMY price is down -1.53% year-on-year

Price 3-year change

-36.33%
BMY price is down -36.33% over the past 3 years

Price Range

Price All-time high

$81.44
BMY price is currently -39.19% below its historical high of $81.44

Price 3-year low

$39.35
BMY price is currently +25.84% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$100.49B
BMY market capitalization is $100.49 billion

Market cap 3-year change

-39.31%
BMY market capitalization is down -39.31% over the past 3 years

Market cap All-time high

$172.50B
BMY market capitalization is currently -41.74% below its historical high of $172.50 billion

Market cap sector rank

98.36%
BMY market capitalization is higher than 98.36% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+0.11%
BMY shares outstanding is up +0.11% year-on-year

Shares Outstanding 3-Year Change

-4.69%
BMY shares outstanding is down -4.69% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

0.13
BMY beta is 0.13

200-day SMA

$53.40
BMY price is currently -7.26% below its 200-day simple moving average

50-day SMA

$58.40
BMY price is currently -15.20% below its 50-day simple moving average

RSI

32.39
BMY 14-day relative strength index is 32.39

Volume

1.41
BMY 30-day relative volume is 1.41

ATR

$2.34
BMY average true range is $2.34

10-day Historical Volatility

36.49%
BMY 10-day historical volatility is 36.49%

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$0.62
BMY last dividend was $0.62 per share, with an ex-dividend date of April 4, 2025

Next Dividend

-
BMY next dividend has not yet been announced

Dividend per share

Dividend per share

$2.40
BMY annual dividend per share is $2.40

Dividend per share Sector Rank

75.58%
BMY annual dividend per share is higher than 75.58% of companies in Healthcare sector

Dividend per share 1-Year Change

+5.26%
BMY annual dividend per share is up +5.26% year-on-year

Dividend per share 3-Year Change

+22.45%
BMY annual dividend per share is up +22.45% over the past 3 years

Dividend yield

Dividend yield

4.85%
BMY annual dividend yield is 4.85%

Dividend yield Sector Rank

83.53%
BMY annual dividend yield is higher than 83.53% of companies in Healthcare sector

Other

Payout ratio

-54.35%
BMY annual payout ratio is -54.35%

Dividends paid

$4.86B
BMY annual dividends paid is $4.86 billion

Free cash flow

$13.94B
BMY annual free cash flow is $13.94 billion

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$48.30B
BMY annual revenue is $48.30 billion

Revenue Analysts estimate

$45.72B
BMY annual revenue is currently +5.65% higher than the consensus analysts' forecast

Revenue 1-year change

+7.32%
BMY annual revenue is up +7.32% year-on-year

Revenue Sector rank

98.1%
BMY annual revenue is higher than 98.1% of companies in Healthcare sector

EPS

EPS

-$4.41
BMY annual earnings per share is -$4.41

EPS Analysts estimate

$6.76
BMY annual earnings per share is currently -165.25% lower than the consensus analysts' forecast

EPS 1-year change

-214.25%
BMY annual earnings per share is down -214.25% year-on-year

EPS Sector rank

20.89%
BMY annual earnings per share is higher than 20.89% of companies in Healthcare sector

Profit

Gross profit

$34.33B
BMY annual gross profit is $34.33 billion

Gross margin

71.08%
BMY annual gross profit margin is 71.08%

Operating profit

$5.89B
BMY annual operating income is $5.89 billion

Operating margin

12.19%
BMY annual operating profit margin is 12.19%

Net income

-$8.95B
BMY annual net profit is -$8.95 billion

Net margin

-18.53%
BMY annual net profit margin is -18.53%

Expenses

Total expenses

$42.41B
BMY annual total expenses is $42.41 billion

Operating expenses

$28.45B
BMY annual total operating expenses is $28.45 billion

Cost of goods sold

$13.97B
BMY annual cost of goods sold is $13.97 billion

Selling, general & administrative expenses

$8.41B
BMY annual SGA is $8.41 billion

Depreciation and amortization

$9.60B
BMY annual depreciation & amortization is $9.60 billion

Interest expense

$1.95B
BMY annual interest expense is $1.95 billion

Income tax

$554.00M
BMY annual income tax is $554.00 million

EBIT & EBITDA

EBIT

-$6.43B
BMY annual earnings before interest & taxes is -$6.43 billion

EBITDA

$2.44B
BMY annual EBITDA is $2.44 billion

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$92.60B
BMY annual total assets is $92.60 billion

Non current assets

$62.82B
BMY annual long term assets is $62.82 billion

Current assets

$10.35B
BMY annual total current assets is $10.35 billion

Cash and cash equivalents

$10.35B
BMY annual cash & cash equivalents is $10.35 billion

Accounts receivable

$9.01B
BMY annual accounts receivable is $9.01 billion

Inventory

$2.56B
BMY annual inventory is $2.56 billion

Liabilities

Total liabilities

$76.22B
BMY annual total liabilities is $76.22 billion

Long term liabilities

$52.44B
BMY annual total long term liabilities is $52.44 billion

Current liabilities

$23.77B
BMY annual total current liabilities is $23.77 billion

Accounts payable

$3.60B
BMY annual accounts payable is $3.60 billion

Debt

Total debt

$51.20B
BMY annual total debt is $51.20 billion

Total debt 1-year change

+23.48%
BMY annual total debt is up +23.48% year-on-year

Long term debt

$48.97B
BMY annual long term debt is $48.97 billion

Short term debt

$2.23B
BMY annual short term debt is $2.23 billion

Equity & Capital

Shareholders equity

$16.34B
BMY annual stockholders equity is $16.34 billion

Book value

$16.34B
BMY annual book value is $16.34 billion

Retained earnings

$14.91B
BMY annual retained earnings is $14.91 billion

Working capital

$6.01B
BMY annual working capital is $6.01 billion

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$15.19B
BMY annual cash flow from operations is $15.19 billion

Cash from operations 1-year change

+9.6%
BMY annual cash flow from operations is up +9.6% year-on-year

Cash from investing

-$21.35B
BMY annual cash flow from investing activities is -$21.35 billion

Cash from investing 1-year change

-830.37%
BMY annual cash flow from investing activities is down -830.37% year-on-year

Cash from financing

$5.13B
BMY annual cash flow from financing activities is $5.13 billion

Cash from financing 1-year change

+154.45%
BMY annual cash flow from financing activities is up +154.45% year-on-year

CAPEX

CAPEX

$1.25B
BMY annual capital expenditures is $1.25 billion

CAPEX 1-year change

+3.23%
BMY annual capital expenditures is up +3.23% year-on-year

Free Cash Flow

Free cash flow

$13.94B
BMY annual free cash flow is $13.94 billion

Free cash flow 1-year change

+10.2%
BMY annual free cash flow is up +10.2% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

71.08%
BMY annual gross profit margin is 71.08%

Operating margin

12.19%
BMY annual operating profit margin is 12.19%

Net margin

-18.53%
BMY annual net profit margin is -18.53%

ROA & ROE

ROA

-9.53%
BMY annual return on assets is -9.53%

ROE

-39.01%
BMY annual return on equity is -39.01%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
BMY price to earnings ratio value is unknown

PE ratio Sector rank

-
BMY price to earnings ratio is unknown

PB Ratio

PB ratio

6.15
BMY price to book ratio is 6.15

PB ratio Sector rank

87.34%
BMY price to book ratio is higher than 87.34% of companies in Healthcare sector

PS Ratio

PS ratio

2.08
BMY price to sales ratio is 2.08

PS ratio Sector rank

44.36%
BMY price to sales ratio is higher than 44.36% of companies in Healthcare sector

Enterprise value

Enterprise value

$141.35B
BMY enterprise value is $141.35 billion

Enterprise value Sector rank

98.6%
BMY enterprise value is higher than 98.6% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

47.42
BMY EV/EBITDA is 47.42

EV/EBITDA Sector rank

97.4%
BMY EV/EBITDA is higher than 97.4% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.25
BMY annual current ratio is 1.25

Quick ratio

0.33
BMY annual quick ratio is 0.33

Leverage

Debt to equity

3.04
BMY annual debt to equity ratio is 3.04

Interest coverage ratio

-3.30
BMY annual interest coverage ratio is -3.30

Risk & Stability

Piotroski F-Score

4
BMY piotroski f-score is 4

Altman Z-Score

1.39
BMY altman z-score is 1.39

Analyst ratings

Recent major analysts updates

Feb 7, 25 Wells Fargo
Equal-Weight
Feb 4, 25 Cantor Fitzgerald
Neutral
Jan 28, 25 Citigroup
Neutral
Jan 8, 25 Truist Securities
Buy
Dec 16, 24 Jefferies
Buy
Nov 15, 24 Wolfe Research
Peer Perform
Nov 12, 24 Morgan Stanley
Underweight
Nov 12, 24 Leerink Partners
Outperform
Nov 12, 24 Citigroup
Neutral
Nov 12, 24 BMO Capital
Market Perform

Institutional Ownership

Similar stocks

MDT logo
Medtronic (MDT)
ELV logo
Elevance Health (ELV)
VRTX logo
Vertex Pharmaceuticals Incorporated (VRTX)
PFE logo
Pfizer (PFE)
SNY logo
Sanofi (SNY)
CVS logo
CVS Health (CVS)
CI logo
Cigna (CI)
GILD logo
Gilead Sciences (GILD)
MCK logo
McKesson (MCK)
  • What is the ticker symbol for Bristol-Myers Squibb?
  • Does Bristol-Myers Squibb pay dividends?
  • What sector is Bristol-Myers Squibb in?
  • What industry is Bristol-Myers Squibb in?
  • What country is Bristol-Myers Squibb based in?
  • When did Bristol-Myers Squibb go public?
  • Is Bristol-Myers Squibb in the S&P 500?
  • Is Bristol-Myers Squibb in the NASDAQ 100?
  • Is Bristol-Myers Squibb in the Dow Jones?
  • When was Bristol-Myers Squibb's last earnings report?
  • When does Bristol-Myers Squibb report earnings?
  • Should I buy Bristol-Myers Squibb stock now?

What is the ticker symbol for Bristol-Myers Squibb?

The ticker symbol for Bristol-Myers Squibb is NYSE:BMY

Does Bristol-Myers Squibb pay dividends?

Yes, Bristol-Myers Squibb pays dividends. The last payment was $0.62, with an ex-dividend date on April 4, 2025

What sector is Bristol-Myers Squibb in?

Bristol-Myers Squibb is in the Healthcare sector

What industry is Bristol-Myers Squibb in?

Bristol-Myers Squibb is in the Drug Manufacturers - General industry

What country is Bristol-Myers Squibb based in?

Bristol-Myers Squibb is headquartered in United States

When did Bristol-Myers Squibb go public?

Bristol-Myers Squibb's initial public offering (IPO) was on June 1, 1972

Is Bristol-Myers Squibb in the S&P 500?

Yes, Bristol-Myers Squibb is included in the S&P 500 index

Is Bristol-Myers Squibb in the NASDAQ 100?

No, Bristol-Myers Squibb is not included in the NASDAQ 100 index

Is Bristol-Myers Squibb in the Dow Jones?

No, Bristol-Myers Squibb is not included in the Dow Jones index

When was Bristol-Myers Squibb's last earnings report?

Bristol-Myers Squibb's most recent earnings report was on Feb 6, 2025

When does Bristol-Myers Squibb report earnings?

The next expected earnings date for Bristol-Myers Squibb is Apr 24, 2025

Should I buy Bristol-Myers Squibb stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page